Business
Little Green Pharma Gets Final Permits and Plans to Commence Commercial Medical Cannabis Production in Australia Within Weeks
Little Green Pharma Gets Final Permits and Plans to Commence Commercial Medical Cannabis P...
About this update from Elixxer Ltd.
[{"type":"text","content":"\n\n\n\nLittle Green Pharma Gets Final Permits and Plans to Commence Commercial Medical Cannabis Production in Australia Within Weeks\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONTREAL, Oct. 23, 2017\n\n\n\nMONTREAL, Oct. 23, 2017 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) (\"LGC\") is pleased to advise that \"Little Green Pharma\", has now received their final permits from the Australian Government enabling them to move to their first commercial production of Medical Cannabis for the Australian market. \n\nLittle Green Pharma have also advised LGC that they plan to start growing within weeks.\n\nJohn McMullen, LGC Capital's CEO, comment; \"Little Green Pharma have advised us that they have now received their final permits from the Australian Government to commence commercial production of Medical Cannabis for the Australian Market and they plan to be growing within weeks. Not only are Little Green Pharma one of the few licenced companies in Australia in the sector, but now they are also one of the very few companies permitted to grow Medical Cannabis for commercial production. LGC Capital is pleased that we have become a shareholder of Little Green Pharma just as they commence their journey down the path of commercial production. We believe that this investment will prove to be a resounding win-win for both Little Green Pharma and LGC.\"\n\nFleta Solomon, Little Green Pharma's Managing Director, commented; \"We are in the process of importing seeds and look forward to the imminent planting of our chosen medicinal cannabis strains. Discussions are underway with local and international leading researchers in a collaborative approach to examine the effect of medicinal cannabis on general cognitive deficit in dementia and PTSD.\"\n\nLGC owns an initial 4.99% of Habi Pharma Pty Ltd of Perth, Australia, doing business as \"Little Green Pharma\", and subject to certain Australian regulatory and other approvals, can potentially increase its interest in Little Green Pharma up to 19.03%.\n\nAbout Little Green Pharma:\n\nLittle Green Pharma ...